Kaddour Chabane

Pierre-la-treiche, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Development and External Validation of a Transcriptome-Based Multivariable Prediction Model for Treatment-Free Remission in Chronic Myeloid Leukemia.

Development and External Validation of a Transcriptome-Based Multivariable Prediction Model for Treatment-Free Remission in Chronic Myeloid Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 15, 2026

Detecting unannotated splicing events in short-read RNA-seq with SAMI, a UMI-aware Nextflow pipeline.

Detecting unannotated splicing events in short-read RNA-seq with SAMI, a UMI-aware Nextflow pipeline.

Journal: Bioinformatics (Oxford, England)

Published: October 17, 2025

Real life evaluation of AlphaMissense predictions in hematological malignancies.

Real life evaluation of AlphaMissense predictions in hematological malignancies.

Journal: Leukemia

Published: October 25, 2023

Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia.

Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia.

Journal: The Journal of molecular diagnostics : JMD

Published: November 21, 2022

Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.

Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.

Journal: Haematologica

Published: January 29, 2022

Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies.

Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies.

Journal: HemaSphere

Published: September 04, 2020

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.

Journal: Leukemia

Published: November 08, 2019

Molecular analysis of a CD19-negative diffuse large B-cell lymphoma.

Molecular analysis of a CD19-negative diffuse large B-cell lymphoma.

Journal: Haematologica

Published: December 14, 2018

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life.

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life.

Journal: Blood

Published: June 06, 2018

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.

Journal: International journal of molecular sciences

Published: March 15, 2018

Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.

Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.

Journal: Clinical genetics

Published: December 15, 2017

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Journal: Haematologica

Published: November 24, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026